CD8A and neoplasm: Despite mediating anti-tumor responses through recruiting immune cells into tumors, activating effector CD8+ T cells, and promoting Th1 polarization, Th17 cells activate angiogenesis and immunosuppressive activities, leading to tumor progression in some models [38].